Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).

Lei LiangMing-Da WangYao-Ming ZhangWan-Guang ZhangCheng-Wu ZhangWan Yee LauFeng ShenTimothy M PawlikDong-Sheng HuangTian Yang

Published in: Journal of hepatocellular carcinoma (2021)

Postoperative biomarker response of serum AFP can be used in predicting recurrence and survival for high-AFP HCC patients. Once postoperative IBR was identified at first follow-up, subsequent enhanced recurrence surveillance and available treatments against recurrence should actively be considered.

Keyphrases

free survival
patients undergoing
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes